Abortion pill manufacturer GenBioPro filed suit against US_FDA to maintain its ability to market the drug. GenBioPro manufactures a generic version of mifepristone, the first drug in a two-step chemical abortion process.
GenBioPro manufactures a generic version of mifepristone, the first drug in a two-step chemical abortion process, which it argued"provides patients with a safe, effective, noninvasive medication option for terminating a pregnancy."The lawsuit, which was filed in a federal court in Maryland, comes as the Supreme Court reviews a 5th Circuit ruling on a Texas decision invalidating the FDA's approval of the pill.
Noting the legal landscape, which has seen four different actions from separate courts with one awaiting Supreme Court review, GenBioPro argued,"These circumstances are unprecedented. No court in history has ever 'stayed' or 'suspended' a longstanding FDA approval, and FDA has no template for responding to — or implementing — those decisions."
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Abortion pill company GenBioPro asks U.S. court to keep generic mifepristone on marketThe Supreme Court is considering whether to maintain a court order that would severely restrict access to the abortion drug mifepristone.
Read more »
As Supreme Court Weighs Next Steps on Abortion Pill, Protesters Rally and Pharma Company GenBioPro Sues FDA to Restore AccessAs the Supreme Court weighs its options on the abortion pill mifepristone, abortion and women’s rights supporters across the U.S. are protesting the latest efforts to restrict access to abortion.
Read more »
Abortion-pill rulings could break the FDA, drug companies sayPharmaceutical companies have mobilized against a pair of lower-court rulings restricting access to abortion pills that they contend go far beyond issues of reproductive health and pose a threat to the regulatory foundations of the U.S. drug industry.
Read more »
Abortion pill manufacturer sues FDA to keep drug on the marketThe Supreme Court is expected to rule today on whether to impose restrictions to abortion pills.
Read more »
Abortion pill maker sues FDA to preserve accessThe maker of the generic version of the abortion pill mifepristone sued the FDA today, hoping to bar the agency from rolling back access to the drug if the Supreme Court allows sweeping restrictions to take effect this week.
Read more »
Abortion Pill Manufacturer Sues FDA to Protect Mifepristone AccessGenBioPro, the manufacturer of a generic version of the abortion pill mifepristone, sued the Food and Drug Administration on Wednesday to prevent the drug from being taken off the market.
Read more »